News
9m
TAG24 on MSNWeight loss jabs linked to lower dementia and stroke riskWeight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...
A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...
Researchers say findings indicate the drugs offer neuroprotective benefits beyond glucose control and weight loss. Experts say it’s a link that needs further study. Doctors have found a way to ...
Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...
New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone ...
If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...
I fear marriage, and I fear becoming a mother. Watching what my mum went through…I just don’t want to go through that.
A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results